Banyan Biomarkers is a company that creates products to help diagnose those who are brain injured. They have recently been granted a new US patent by the US Patent and Trademark Office. The patent is for proteolytic biomarkers that will be used for the detection of traumatic brain injuries. The patent itself describes a novel method of determining brain injuries. This determination would be done by the use of proteolytic breakdown products of MAP’s. MAP’s are microtubule-associated proteins. These MAP’s will allow better detection of traumatic brain injuries and may increasingly find use in the future. Currently many different types of brain injuries are fairly difficult to detect even with sophisticated brain scanning. Subtle types of brain damage especially to the axons and dendrites of neurons can be difficult to spot. It wouldn’t show up as a gross morphology change on an MRI or CT scan. However these proteolytic proteins have the ability to detect more subtle forms of brain injury. They also may diagnose brain injury faster than other methods. This would allow the administration of treatment at a quicker rate. This could reduce the damaging after effects of a traumatic brain insult.